A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients

被引：0
|
作者：
Rajiv Kumar
Shir Kiong Lu
Anna Minchom
Adam Sharp
Michael Davidson
Ranga Gunapala
Timothy A. Yap
Jaishree Bhosle
Sanjay Popat
Mary E. R. O’Brien
机构：
[1] The Royal Marsden NHS Foundation Trust,Department of Medicine
[2] The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 77卷
关键词：
Non-small cell lung cancer; Adenocarcinoma; Capecitabine; Erlotinib; Phase 1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 383
页数：8
相关论文
共 50 条
  • [1] A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients
    Kumar, Rajiv
    Lu, Shir Kiong
    Minchom, Anna
    Sharp, Adam
    Davidson, Michael
    Gunapala, Ranga
    Yap, Timothy A.
    Bhosle, Jaishree
    Popat, Sanjay
    O'Brien, Mary E. R.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (02) : 375 - 383
  • [2] Phase 1b study of capecitabine and erlotinib in advanced non-small cell lung cancer
    Lu, S.
    Popat, S.
    Puglisi, M.
    Kaudeer, N.
    Gennatas, S.
    Hewish, M.
    Ayite, B.
    Bhosle, J.
    O'Brien, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S828 - S828
  • [3] A Phase 1b Trial of the Combination of Capecitabine and Erlotinib in Advanced Lung Cancer
    Kumar, Rajiv
    Lo, Karl
    Minchom, Anna R.
    Sharp, Adam
    Davidson, Michael
    Gunapala, Ranga
    Yap, Timothy
    Bhosle, Jaishree
    Popat, Sanjay
    O'Brien, Mary E. R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S547 - S548
  • [4] A PHASE 1B STUDY OF AMG 655 IN COMBINATION WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Paz-Ares, L.
    Torres, J. M. Sanchez
    Diaz-Padilla, I.
    Links, M.
    Reguart, N.
    Boyer, M.
    Wiezorek, J.
    Sabin, T.
    Hsu, M.
    Van Meerbeeck, J.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 161 - 161
  • [5] An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer
    Carreca, Ignazio
    Bronte, Giuseppe
    Burgio, Marco
    Carreca, Annapaola
    Piazza, Dario
    Rizzo, Sergio
    Russo, Salvatore
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 159 - 159
  • [6] Phase 1b Trial of Cabozantinib or Cabozantinib Plus Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Lim, F.
    Ponce, S.
    Patel, S.
    Van Herpen, C.
    Kurkjian, C.
    Lou, Y.
    Liu, Y.
    Ramsingh, G.
    Pal, S.
    Neal, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S405 - S406
  • [7] HERALD: A PHASE 1B/2 TRIAL OF HER3 INHIBITOR U3-1287 IN COMBINATION WITH ERLOTINIB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Von Pawel, Joachim
    Tseng, Jennifer
    Dediu, Mircea
    Schumann, Christian
    Copigneaux, Catherine
    Beckman, Robert A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S119 - S120
  • [8] Phase I trial of vorinostat in combination with erlotinib in advanced non-small cell lung cancer (NSCLC) patients with EGFR mutations after erlotinib progression
    Reguart, N.
    Cardona, A. F.
    Isla, D.
    Cardenal, F.
    Palmero, R.
    Carrasco-Chaumel, E.
    Rolfo, C.
    Massuti, B.
    Moran, T.
    Rosell, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] PHASE 1 STUDY OF ORAL VINORELBINE IN COMBINATION WITH ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) USING A METRONOMIC SCHEDULE
    Chua, Clarinda
    Chowbay, Balram
    Tan, Eng-Huat
    Hui, Kam-Man
    Toh, Chee-Keong
    Leong, Swan-Swan
    Ang, Mei-Kim
    Ng, Raymond
    Hou, Xuan
    Lim, Wan-Teck
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1246 - S1247
  • [10] Phase I trial of vorinostat in combination with erlotinib for advanced non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations after erlotinib progression
    Reguart, Noemi
    Isla, Dolores
    Cardenal, Felipe
    Cardona, Andres
    Palmero, Ramon
    Moran, Teresa
    Rolfo, Christian Diego
    Nadal, Ernesto Samuel
    Massuti, Tomeu
    Montanes, Ana
    Queralt, Cristina
    Taron, Miquel
    Rosell, Rafael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S708 - S708
12345